Skip to content

Clinical trials

Hepatitis, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis, Chronic Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20031
20051
20061
20075
20085
20096
20104
20114
20123
20138
20143
20153
20166
20184
20194
20201
20211
20224
20231
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Unknown status13
Recruiting9
Terminated8
Active, not recruiting1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)7
Gilead Sciences6
Cytheris SA4
Bristol-Myers Squibb3
Pfizer3
AusperBio Therapeutics Inc.2
Casa Sollievo della Sofferenza IRCCS2
GlaxoSmithKline2
Kindai University2
National Cancer Institute (NCI)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis, Chronic78
Hepatitis C27
Liver Diseases23
Hepatitis20
Hepatitis B16
Hepatitis C, Chronic16
Virus Diseases16
Hepatitis B, Chronic15
Hepatitis, Viral, Human13
Liver Cirrhosis12

Trials

Showing 26 to 50 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.